Newly recognised tool from iHeart determines “internal age” via aortic stiffness
NattoPharma, the world leaders in vitamin K2 research and development, has confirmed and cultivated an understanding that K2 supports cardiovascular health by activating proteins that inhibit arterial calcification.
So it is understandable that NattoPharma is excited to be teaming with a company that has pioneered a system that helps to determine one’s “internal age” by measuring aortic stiffness via pulse wave velocity (PWV).
The iHeart system is the perfect complement to NattoPharma’s clinically validated cardiovascular and bone support ingredient, MenaQ7 vitamin K2 as MK-7.
The iHeart system calculates one’s internal age, a measure of aortic stiffness relative to others the same age, using Aortic Pulse Wave Velocity (AoPWV).
AoPWV is the speed a pulse wave travels down the aorta, the body’s largest blood vessel. AoPWV has been proven to be a powerful predictor for risk of heart disease, stroke and dementia, whereas aortic stiffness has been linked to inadequate dietary intakes, specifically vitamin K2, as substantiated in population and clinical studies.
iHeart provides a snapshot of current heart health and objectively shows benefit of vitamin K2 supplementation.
“By analysing the fingertip arterial pulse signal, our system calculates the aortic pulse wave velocity within 30 seconds, which then allows users to track the effects of lifestyle choices on their internal age,” says Dr Jess Goodman, the creator of the iHeart system.
A Canadian general practitioner and medical adviser at three long-term care facilities, Dr Goodman is well aware of the importance of physical activity for health maintenance.
He “wanted to provide a simple, easy-to-use metric that showed health benefit of regular exercise. Aortic stiffness served this purpose well, being a parameter proven to predict the risk of death from all causes and shown to improve with exercise.”
“Our 3-year cardiovascular study measured pulse wave velocity to determine that a nutritional dose of MenaQ7 improved arterial stiffness. And now the iHeart system provides a quick, non-invasive way to calculate one’s aortic pulse wave velocity, designating whether they could benefit from Vitamin K2 supplementation,” says Eric Anderson, SVP Global Marketing and Business Development.
iHeart will be at NattoPharma’s SupplySide West booth (P115) demonstrating this amazing technology, which is a perfect match for NattoPharma’s clinically proven and patented MenaQ7 vitamin K2 as MK-7.
Plan to come by to get your iHeart measurement. Visit www.goiheart.com to find out more about the iHeart system, and www.MenaQ7.com to learn more about this expert vitamin K2 brand.